JPH08506796A - ペプチドグリカン単量体(pgm),そのn−アシル誘導体及びその金属錯体の、生体における免疫抑制状態及び肝抑制状態を補正するための薬剤調製への使用 - Google Patents
ペプチドグリカン単量体(pgm),そのn−アシル誘導体及びその金属錯体の、生体における免疫抑制状態及び肝抑制状態を補正するための薬剤調製への使用Info
- Publication number
- JPH08506796A JPH08506796A JP5504098A JP50409893A JPH08506796A JP H08506796 A JPH08506796 A JP H08506796A JP 5504098 A JP5504098 A JP 5504098A JP 50409893 A JP50409893 A JP 50409893A JP H08506796 A JPH08506796 A JP H08506796A
- Authority
- JP
- Japan
- Prior art keywords
- pgm
- state
- liver
- carboxylic acid
- acid group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Addiction (AREA)
- Hematology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Obesity (AREA)
- Psychiatry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
YU141291 | 1991-08-15 | ||
PCT/EP1992/001859 WO1993003746A1 (fr) | 1991-08-15 | 1992-08-13 | Preparation de medicaments contenant le monomere de peptidoglycane ou ses derives |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH08506796A true JPH08506796A (ja) | 1996-07-23 |
Family
ID=25554075
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP5504098A Pending JPH08506796A (ja) | 1991-08-15 | 1992-08-13 | ペプチドグリカン単量体(pgm),そのn−アシル誘導体及びその金属錯体の、生体における免疫抑制状態及び肝抑制状態を補正するための薬剤調製への使用 |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0600974A1 (fr) |
JP (1) | JPH08506796A (fr) |
BG (1) | BG98628A (fr) |
CA (1) | CA2115270A1 (fr) |
CZ (1) | CZ30194A3 (fr) |
HR (1) | HRP920488A2 (fr) |
HU (1) | HU9400420D0 (fr) |
RU (1) | RU94027699A (fr) |
SK (1) | SK17994A3 (fr) |
WO (1) | WO1993003746A1 (fr) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
YU45382B (en) * | 1986-11-19 | 1992-05-28 | Pliva Sour Zagreb | Process for preparing complex of n-acethyl-glucosis-aminyl-n-acethyl-muramoil-l-alanyl-d-izoglutaminyl-(l)-mezodiaminopimelyl-(d-amid)-(l)-al |
US4868155A (en) * | 1987-10-05 | 1989-09-19 | Merck & Co., Inc. | Dipeptidyl 4-0-,6-0-acyl-2-amino-2-deoxy-D-glucose compositions and methods of use in AIDS-immunocompromised human hosts |
YU62689A (en) * | 1989-03-27 | 1991-02-28 | Pliva Pharm & Chem Works | N-acyl derivatives of peptidoglican monomer, their pharmaceutically acceptable salts, process for preparing thereof and their use as immunity modulators and immunoadjuvant |
-
1992
- 1992-08-13 JP JP5504098A patent/JPH08506796A/ja active Pending
- 1992-08-13 RU RU94027699/14A patent/RU94027699A/ru unknown
- 1992-08-13 CZ CS94301A patent/CZ30194A3/cs unknown
- 1992-08-13 SK SK179-94A patent/SK17994A3/sk unknown
- 1992-08-13 EP EP92917699A patent/EP0600974A1/fr not_active Withdrawn
- 1992-08-13 WO PCT/EP1992/001859 patent/WO1993003746A1/fr not_active Application Discontinuation
- 1992-08-13 CA CA002115270A patent/CA2115270A1/fr not_active Abandoned
- 1992-08-13 HU HU9400420A patent/HU9400420D0/hu unknown
- 1992-09-25 HR HR920488A patent/HRP920488A2/hr not_active Application Discontinuation
-
1994
- 1994-03-01 BG BG98628A patent/BG98628A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CZ30194A3 (en) | 1994-06-15 |
CA2115270A1 (fr) | 1993-03-04 |
HU9400420D0 (en) | 1994-08-29 |
RU94027699A (ru) | 1996-04-10 |
HRP920488A2 (en) | 1994-08-31 |
BG98628A (en) | 1995-06-30 |
EP0600974A1 (fr) | 1994-06-15 |
WO1993003746A1 (fr) | 1993-03-04 |
SK17994A3 (en) | 1994-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0167263B1 (fr) | Matrices contenant des médicaments pour introduction dans des zones de lésions cellulaires | |
JP3623962B2 (ja) | ヒドロキソコバラミンの鼻中投与用医薬組成物 | |
AU2010241263B2 (en) | Use of Growth Hormone Releasing Factor Analogs in Treating Patients Suffering from Wasting | |
JPS6226218A (ja) | がん性腫瘍転移の治療剤 | |
CZ4997A3 (en) | Preparation for regulating immune functions and regulation method of immunity system disorders | |
CA2176298C (fr) | Traitement a l'aide de fluoroquinolone, en dose unique elevee | |
JP2005527592A (ja) | α−ケトアルカン酸または−エステルもしくは−アミドを用いる腸閉塞の処置方法 | |
JP2006524227A5 (fr) | ||
Park et al. | Efficacy of D-CPPene, a competitive N-methyl-D-aspartate antagonist in focal cerebral ischemia in the rat | |
EP1450850B1 (fr) | Methode d'administration d'un peptide alpha 1 de la thymosine | |
JP4672257B2 (ja) | エポチロンを含む組成物およびカルチノイド症候群の治療のためのそれらの使用 | |
JPH11505222A (ja) | 2〜6時間の活性成分放出期間をもつ上皮小体ホルモンの医薬投与形態 | |
JPH08506796A (ja) | ペプチドグリカン単量体(pgm),そのn−アシル誘導体及びその金属錯体の、生体における免疫抑制状態及び肝抑制状態を補正するための薬剤調製への使用 | |
JP2007537280A (ja) | 免疫調節性化合物を用いる呼吸器のウイルス感染の治療又は予防 | |
US7906486B2 (en) | Method of treating or preventing tissue deterioration, injury or damage due to disease of mucosa | |
JPH11504011A (ja) | 疼痛の治療方法 | |
EP1099446B1 (fr) | Composition pour le traitement de la dépression et de l'anxieté contenant un antagoniste du récepteur NK-1 et un agent antidépressant ou anxiolitique | |
Hanssen et al. | Extended Experience with Recombinant a-2b Interferon with OR Without Hepatic Artery Embolization in the Treatment OF Midgut Carcinoid Tumours A preliminary report | |
JP2001526217A (ja) | 血管性頭痛に対する局所麻酔薬の新規な使用 | |
JPH11511479A (ja) | 1,2,4−ベンゾトリアジンオキシド製剤 | |
KR880003973A (ko) | 약리적 활성 화합물 및 용도 | |
WHITE et al. | Gallamine in anesthesia for patients with chronic renal failure undergoing bilateral nephrectomy | |
KR20090103656A (ko) | 섬유근육통 치료제 | |
Boughton | Drug points: Cardiac side effects of pentamidine | |
Barrett et al. | Drug points: Hypertension in association with buserelin |